KindlyMD, Inc. (NASDAQ:NAKA) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Analysts give KindlyMD a consensus rating of "Hold" (1 sell, 1 hold, 3 buy) with an average 1-year target price of $0.75, while recent notes include price-target cuts from B. Riley (to $0.50) and Maxim (to $0.75) and a new buy initiation from TD Cowen at $1.00.
• Several institutions have established or sharply increased positions—most notably Vanguard (owning ~6.04M shares after adding ~6.02M), VanEck, Yorkville and RK Capital—indicating substantial institutional buying interest.
• The stock is currently trading around $0.23 with a market cap of about $156.6M, wide 12-month range ($0.21–$34.77) and high volatility (beta ~26.7), reflecting significant price swings despite low current valuations.

Shares of KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) have earned an average rating of "Hold" from the five research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $0.75.

NAKA has been the topic of several research reports. B. Riley Financial dropped their price objective on KindlyMD from $1.00 to $0.50 and set a "buy" rating for the company in a report on Monday, February 23rd. Weiss Ratings reissued a "sell (e+)" rating on shares of KindlyMD in a report on Friday, March 27th. Maxim Group dropped their price objective on KindlyMD from $1.50 to $0.75 and set a "buy" rating for the company in a report on Monday. Finally, TD Cowen began coverage on KindlyMD in a report on Friday. They set a "buy" rating and a $1.00 price objective for the company.

Institutional Trading of KindlyMD

A number of institutional investors and hedge funds have recently modified their holdings of NAKA. Van ECK Associates Corp bought a new stake in KindlyMD during the 3rd quarter worth approximately $111,339,000. Vanguard Group Inc. increased its stake in KindlyMD by 32,737.0% during the 3rd quarter. Vanguard Group Inc. now owns 6,036,750 shares of the company's stock worth $150,557,000 after purchasing an additional 6,018,366 shares in the last quarter. Correct Capital Wealth Management bought a new stake in KindlyMD during the 3rd quarter worth approximately $111,339,000. Yorkville Advisors Global LP bought a new stake in KindlyMD during the 3rd quarter worth approximately $231,942,000. Finally, RK Capital Management LLC FL bought a new stake in KindlyMD during the 3rd quarter worth approximately $239,052,000.

KindlyMD Stock Performance

Shares of NASDAQ:NAKA traded up $0.02 on Friday, hitting $0.23. The stock had a trading volume of 1,983,678 shares, compared to its average volume of 5,008,176. The firm's 50 day moving average price is $0.26 and its 200-day moving average price is $0.51. The company has a market capitalization of $156.63 million, a price-to-earnings ratio of -0.26 and a beta of 26.73. KindlyMD has a twelve month low of $0.21 and a twelve month high of $34.77.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.